Yingxue Chen, PhD

Ipsen

Primarily trained as a Pharmacist, Yingxue also received her Ph.D. in Pharmacology and Toxicology, as well as post-doc training in Clinical Pharmacokinetics from the University of Kansas. She then worked at Biogen Idec, Takeda (Millennium Oncology), Vertex Pharmaceuticals, and AstraZeneca as a clinical pharmacologist lead in the therapeutic areas of oncology, CNS, and rear disease.

Yingxue joined Ipsen early 2021 and is currently working on early and late-stage oncology projects.

Poster(s):

• PI-078 - PHARMACOKINETIC INTERACTION STUDIES OF COADMINISTRATION OF TAZEMETOSTAT WITH FLUCONAZOLE, REPAGLINIDE, OR OMEPRAZOLE IN PATIENTS WITH ADVANCED MALIGNANCIES.
  Wednesday, May 28, 2025

  5:00 PM - 6:30 PM East Coast USA Time